Bristol Myers Squibb is adding three prescription medications on TrumpRx.gov on Monday, offering discounts of up to 90%, FOX Business has learned.
How will AI reshape the healthcare industry? Christopher Boerner discusses changing R&D strategies, improved medicines based ...
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might ...
Is BMY a good stock to buy? We came across a bullish thesis on Bristol-Myers Squibb Company on MaxDividends’s Substack by Serhio MaxDividends. In this article, we will summarize the bulls’ thesis on ...
Boring is beautiful. That adage is especially true during turbulent times. If you haven't noticed, the current market and ...
We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in ...
Bristol-Myers Squibb Company (NYSE:BMY) is included in our list of the best stocks to buy for financial stability. Bristol-Myers Squibb Company (NYSE:BMY) is facing mixed analyst sentiment, with ...
The past five years have been challenging for Bristol Myers Squibb (NYSE: BMY). The company lost patent exclusivity for some key products, including one that was once its best-selling medicine, cancer ...
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy.
Bristol Myers’ Camzyos shows strong Phase 3 results for teens with obstructive hypertrophic cardiomyopathy, boosting approval hopes and new ...
Bristol Myers Squibb (NYSE: BMY) will announce results for the first quarter of 2026 on Thursday, April 30, 2026. Company executives will review financial results with the investment community during ...
Deep-pocketed investors have adopted a bullish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results